How Does LC-MS/MS Testing Improve CAH Hormone Monitoring?
At a Glance
LC-MS/MS is a more specific blood-testing method for congenital adrenal hyperplasia because it separates similar steroid hormones before measuring them. It can reduce falsely high results, but treatment decisions still depend on symptoms, growth, blood pressure, electrolytes, and dose timing.
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) is a highly precise blood testing method used to measure hormone levels [1]. Many CAH specialists prefer this method when available because traditional tests can easily confuse the many similar steroid hormones in your blood, resulting in artificially high readings [2]. While no test is perfect, LC-MS/MS provides more reliable steroid measurements that complement your doctor’s clinical assessment [3]. This helps your care team avoid misinterpreting cross-reactivity and better adjust your medication to provide adequate hormone replacement while minimizing over-replacement [2][4].
How LC-MS/MS Works
To understand why this test is highly specific, it helps to break down the name:
- Liquid Chromatography (LC): This first step acts like a high-tech filter. It physically separates the complex mixture of hormones in your blood sample so they can be looked at one by one [5].
- Tandem Mass Spectrometry (MS/MS): Once the hormones are separated, this step acts as a molecular scale. It detects characteristic mass-to-charge signals and fragment patterns to identify each specific hormone [5].
Because it separates the compounds and measures their specific molecular properties, LC-MS/MS is much less likely to confuse structurally similar hormones.
The Problem with Some Traditional Tests
Standard blood tests, often called immunoassays, use antibodies designed to latch onto a specific hormone like 17-hydroxyprogesterone (17-OHP) or androstenedione (a weak androgen, or male-type hormone).
However, in classic congenital adrenal hyperplasia (CAH), your body produces a high number of “precursor” hormones—the building blocks your adrenal glands use when trying to make cortisol. Many of these precursors look almost identical to one another. In some immunoassays, the testing antibodies get confused and latch onto the wrong precursor hormones as well [2]. This is called cross-reactivity.
When cross-reactivity happens, the test counts the target hormone plus all the look-alikes. As a result, the lab report may show a falsely elevated number [2].
Why Measurement Accuracy Matters
The difference between testing methods can be significant. In one study of patients with classic 21-hydroxylase deficiency, traditional immunoassay results for 17-OHP and androstenedione were approximately 30% to 50% higher than the levels measured by LC-MS/MS [2]. Note that these differences vary substantially depending on the specific lab, the assay manufacturer, and the patient [6].
If your doctor relies on a test that is artificially high due to cross-reactivity, it may falsely look like your CAH is poorly controlled. This can prompt the doctor to increase your glucocorticoid medication (like hydrocortisone) [2][4]. Over-replacement with glucocorticoids can cause significant long-term side effects, including stunted growth in children, bone density loss, and unwanted weight gain [3].
Important Safety Warning: You should never skip, hold, or change your glucocorticoid dose based on a lab result without direct instructions from your care team. Inadequate replacement can lead to life-threatening adrenal crisis, particularly during illness or physiological stress.
The “Big Picture” of CAH Monitoring
LC-MS/MS allows the lab to measure a multi-steroid panel at the exact same time from a very small blood sample [7]. Instead of just looking at 17-OHP, your specialist might look at hormones like androstenedione, testosterone, and 21-deoxycortisol (a specific precursor marker that heavily builds up in 21-hydroxylase deficiency) [7][2].
However, lab tests are only one part of the picture. Clinicians interpret LC-MS/MS results alongside your clinical symptoms, growth rate, blood pressure, and electrolytes [3][6]. In fact, the goal of treatment is rarely to push every single lab number into the “normal” range, as trying to do so often requires so much medication that it causes overtreatment [8].
Comparing the Tests
| Feature | Immunoassay | LC-MS/MS |
|---|---|---|
| How it measures | Uses antibodies to bind to hormones | Physically separates hormones, then measures molecular mass/charge |
| Specificity | Lower: Antibodies can cross-react with other CAH precursor hormones | Higher: Significantly reduces cross-reactivity |
| Common Limitation | May falsely elevate 17-OHP and androstenedione levels | More expensive, less widely available at local labs |
| Testing Panel | Usually measures one hormone per test | Can measure multiple hormones at once from one sample |
Common questions in this guide
What is LC-MS/MS testing for CAH?
What is the difference between an immunoassay and LC-MS/MS for CAH?
Which hormones may be included in an LC-MS/MS CAH panel?
Can a high CAH lab result mean my hydrocortisone dose should be increased?
How should I time a CAH blood test around my morning hydrocortisone?
Related questions
Show more
Get notified when new evidence is published on Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
Measurement of serum 17-hydroxyprogesterone using isotope dilution liquid chromatography-tandem mass spectrometry candidate reference method and evaluation of the performance for three routine methods.
Long Q, Zhang T, Yan Y, et al.
Clinical chemistry and laboratory medicine 2021; (59(3)):523-532 doi:10.1515/cclm-2020-0410.
PMID: 33554585 - 2
Assay of steroids by liquid chromatography-tandem mass spectrometry in monitoring 21-hydroxylase deficiency.
Dahl SR, Nermoen I, Brønstad I, et al.
Endocrine connections 2018; (7(12)):1542-1550.
PMID: 30530876 - 3
Current insights into monitoring of congenital adrenal hyperplasia.
Leusink QM, Verploegen EEW, Adriaansen BPH, et al.
Frontiers in endocrinology 2026; (17()):1774145 doi:10.3389/fendo.2026.1774145.
PMID: 41767372 - 4
Novel treatments for congenital adrenal hyperplasia.
Schröder MAM, Claahsen-van der Grinten HL
Reviews in endocrine & metabolic disorders 2022; (23(3)):631-645 doi:10.1007/s11154-022-09717-w.
PMID: 35199280 - 5
Best Practice for Identification of Classical 21-Hydroxylase Deficiency Should Include 21 Deoxycortisol Analysis with Appropriate Isomeric Steroid Separation.
Greaves RF, Kumar M, Mawad N, et al.
International journal of neonatal screening 2023; (9(4)) doi:10.3390/ijns9040058.
PMID: 37873849 - 6
Steroid profiling in congenital adrenal hyperplasia: comparing immunoassays and LC-MS/MS accuracy.
Taba-Tabai S, Ozsu E, Cetin SK, et al.
Journal of pediatric endocrinology & metabolism : JPEM 2026; (39(8)):792-802 doi:10.1515/jpem-2025-0538.
PMID: 42380965 - 7
A Liquid Chromatography/Tandem Mass Spectometry Profile of 16 Serum Steroids, Including 21-Deoxycortisol and 21-Deoxycorticosterone, for Management of Congenital Adrenal Hyperplasia.
Fiet J, Le Bouc Y, Guéchot J, et al.
Journal of the Endocrine Society 2017; (1(3)):186-201 doi:10.1210/js.2016-1048.
PMID: 29264476 - 8
Congenital Adrenal Hyperplasia in Children: A Pilot Study of Steroid Hormones Expressed as Sex- and Age-Related Standard Deviation Scores.
Clausen CS, Ljubicic ML, Main KM, et al.
Hormone research in paediatrics 2020; (93(4)):226-238 doi:10.1159/000509079.
PMID: 33017824
This page explains LC-MS/MS testing for CAH for informational purposes only and does not constitute medical advice. Do not change or hold hydrocortisone without instructions from your CAH care team.